Finance

Lists
Why is LTGO up 8.18%?
Dive Deeper
LTGO:NASDAQ
Latigo Biotherapeutics, Inc.
$16.00
+8.18%
(+1.21) 1D
$16.00
0.00% (0.00)
After hours
Closed: Oct 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LTGO...
Open
$14.84
High
$16.08
Low
$14.61
Mkt. cap
1.06B
Avg. vol.
363.39K
Volume
184.22K
52-wk high
$25.90
52-wk low
$14.60
EPS
-$1.76
No. of employees
66
Open
$14.84
High
$16.08
Low
$14.61
Mkt. cap
1.06B
Avg. vol.
363.39K
Volume
184.22K
52-wk high
$25.90
52-wk low
$14.60
EPS
-$1.76
No. of employees
66
News stories
From web sources and news partners
About Latigo Biotherapeutics, Inc.
CEO-
Employees66
Founded2018
Headquarters-
SectorPharmaceutical industry
Websitelatigobio.com
Analyst ratings
Based on 3 analysts giving stock ratings to LTGO in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for LTGO in the last 3 months.
Highest
Current $16.00
$73.00 (+356.25%)
Average
$57.67 (+260.44%)
Lowest
$50.00 (+212.50%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yatin Suneja
Guggenheim
Buy
Initiated
$50.00
+212.5%
09/01/2026
Akash Tewari
Jefferies
Buy
Initiated
$50.00
+212.5%
09/01/2026
Salveen Richter
Goldman Sachs
Buy
Maintained
$73.00
+356.2%
09/01/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
18.69M
22.92M
17.63M
21.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.82M
2.82M
5.80M
4.58M
Operating expense
21.51M
25.74M
23.44M
25.81M
Total operating expenses
21.51M
25.74M
23.44M
25.81M
Operating income
-21.51M
-25.74M
-23.44M
-25.81M
Other non operating income
43.00K
-958.00K
1.00K
-2.00K
EBT including unusual items
-20.95M
-25.84M
-22.96M
-25.80M
EBT excluding unusual items
-20.95M
-25.84M
-22.96M
-25.80M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20.95M
-25.84M
-22.96M
-25.80M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
517.00K
868.00K
474.00K
264.00K
Interest expense
-
-
-
-251.00K
Net interest expenses
517.00K
868.00K
474.00K
13.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.44M
-25.68M
-23.39M
-25.76M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps